凝血功能障碍或抗凝抗血小板治疗对切口疝修补术的影响:Herniamed登记数据
基于Herniamed登记中43101例切口疝修补患者,6668例(15.5%)存在凝血功能障碍或接受抗凝/抗血小板治疗。多变量分析显示该高危组术后出血率3.9%显著高于正常风险组1.6%(OR 2.001,p<0.001),再手术率、总体并发症率和死亡率亦显著升高。腹腔镜腹腔内补片置入术后出血并发症风险似乎较低。
要点
- 高危组术后出血率3.9%,显著高于正常风险组1.6%(OR 2.001,p<0.001)。
- 高危组因出血再手术率2.4% vs 1.0%(OR 1.217,p=0.003),总体并发症和死亡率亦更高。
- 男性、使用引流、较大缺损、开放修补、较低BMI和高ASA评分也增加出血风险。
核心结论
- 接受抗凝或抗血小板治疗或存在凝血功能障碍的切口疝修补患者术后出血风险显著增高。
- 腹腔镜腹腔内补片置入术后出血并发症及并发症相关再手术风险似乎较低。
研究设计与样本
- 基于Herniamed登记数据库的回顾性分析,纳入43101例切口疝修补患者,其中6668例(15.5%)为高危组。
- 采用多变量分析探讨高危因素对术后出血的影响并识别其他影响因素。
主要发现
- 高危组术后出血率3.9%(n=261),正常风险组1.6%(n=564),OR 2.001 [1.699; 2.356],p<0.001。
- 高危组因术后出血再手术率2.4% vs 1.0%,OR 1.217 [1.071; 1.382],p=0.003。
- 高危组术后总体并发症率6.04% vs 3.66%(p<0.001),死亡率0.46% vs 0.17%(p<0.001)。
- 男性、使用引流、较大缺损、开放切口疝修补、较低BMI和高ASA评分显著增加术后出血风险。
临床怎么用
- 对接受抗凝/抗血小板治疗或存在凝血障碍的切口疝患者,术前应充分评估出血风险并优化管理。
- 在条件允许时,可优先考虑腹腔镜腹腔内补片置入术以降低出血并发症风险。
局限性
- 原文未明确报告本研究的具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A considerable number of patients undergoing incisional hernia repair are on anticoagulant or antiplatelet therapy or have existing coagulopathy which may put them at higher risk for postoperative bleeding complications. Data about the optimal treatment of these patients are sparse. This analysis attempts to determine the rate of postoperative bleeding complications following incisional hernia repair and the consecutive rate of reoperation among patients with coagulopathy or receiving antiplatelet and anticoagulant therapy (higher risk group) compared to patients who do not have a higher risk (normal risk group). METHODS: Out of the 43,101 patients documented in the Herniamed Registry who had an incisional hernia repair, 6668 (15.5%) were on anticoagulant or antithrombotic therapy or had existing coagulopathy. The implication of that higher risk profile for onset of postoperative bleeding was investigated in multivariable analysis. Hence, other influential variables were identified. RESULTS: The rate of postoperative bleeding in the higher risk group was 3.9% (n = 261) and significantly higher compared to the normal risk group at 1.6% (n = 564) (OR 2.001 [1.699; 2.356]; p < 0.001). Additionally, male gender, use of drains, larger defect size, open incisional hernia repair, lower BMI, and higher ASA score significantly increased the risk of postoperative bleeding. The rate of reoperations due to postoperative bleeding was significantly increased in the higher risk group compared to the normal risk group (2.4 vs. 1.0%; OR 1.217 [1.071; 1.382]; p = 0.003). Likewise, the postoperative general complication rate (6.04 vs. 3.66%; p < 0.001) as well as the mortality rate (0.46 vs. 0.17%; p < 0.001) were significantly higher in the higher risk group. CONCLUSIONS: Patients with anticoagulant or antiplatelet therapy or existing coagulopathy who undergo incisional hernia repair have a significantly higher risk for onset of postoperative bleeding. The risk of bleeding complications and complication-related reoperations seems to be lower after laparoscopic intraperitoneal onlay mesh.
引用
- Staerkle RF, Hoffmann H, Köckerling F, et al. Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry. Surg Endosc. 2018. PMID: 29492708. doi:10.1007/s00464-018-6127-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。